Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Cella

Showing results (421-430 of 1,016) with videos related to

Pageof 102
Sort By:
Psycho-Oncology|March 29, 2002
Resilience, reflection, and residual stress in ovarian cancer survivorship: a gynecologic oncology group studyLari B Wenzel, James P Donnelly, Jeffery M Fowler, et al.
Gynecologic Oncology|November 16, 2010
A new index of priority symptoms in advanced ovarian cancerSally E Jensen, Sarah K Rosenbloom, Jennifer L Beaumont, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|March 26, 2013
Development and validation of the positive affect and well-being scale for the neurology quality of life (Neuro-QOL) measurement systemJohn M Salsman, David Victorson, Seung W Choi, et al.
Psychological Test and Assessment Modeling|May 20, 2017
Measurement Equivalence of the Patient Reported Outcomes Measurement Information System<sup>®</sup> (PROMIS<sup>®</sup>) Applied Cognition - General Concerns, Short Forms in Ethnically Diverse GroupsRobert Fieo, Katja Ocepek-Welikson, Marjorie Kleinman, et al.
Breast Cancer Research and Treatment|January 21, 2009
Lapatinib plus capecitabine versus capecitabine alone for HER2+ (ErbB2+) metastatic breast cancer: quality-of-life assessmentXiaolei Zhou, David Cella, David Cameron, et al.
Anxiety, Stress, and Coping|January 13, 2015
Assessment of stress and self-efficacy for the NIH Toolbox for Neurological and Behavioral FunctionMary Jo Kupst, Zeeshan Butt, Catherine M Stoney, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|April 12, 2021
Past and Current Practice of Patient-Reported Outcome Measurement in Randomized Cancer Clinical Trials: A Systematic ReviewJohannes M Giesinger, Fabio Efficace, Neil Aaronson, et al.
Journal of Biopharmaceutical Statistics|February 15, 2024
[Special issue PRO] Considering endpoints for comparative tolerability of cancer treatments using patient report given the estimand frameworkJohn Devin Peipert, Monique Breslin, Ethan Basch, et al.
The Oncologist|September 9, 2008
Health-related quality of life impact of bevacizumab when combined with irinotecan, 5-fluorouracil, and leucovorin or 5-fluorouracil and leucovorin for metastatic colorectal cancerFairooz F Kabbinavar, Joel F Wallace, Eric Holmgren, et al.
Medical Care|May 18, 2010
Literacy-fair measurement of health-related quality of life will facilitate comparative effectiveness research in Spanish-speaking cancer outpatientsElizabeth A Hahn, Hongyan Du, Sofia F Garcia, et al.
Pageof 102

Showing results (421-430 of 1,016) with videos related to

Sort By:
Pageof 102
Psycho-Oncology|March 29, 2002
Resilience, reflection, and residual stress in ovarian cancer survivorship: a gynecologic oncology group studyLari B Wenzel, James P Donnelly, Jeffery M Fowler, et al.
Gynecologic Oncology|November 16, 2010
A new index of priority symptoms in advanced ovarian cancerSally E Jensen, Sarah K Rosenbloom, Jennifer L Beaumont, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|March 26, 2013
Development and validation of the positive affect and well-being scale for the neurology quality of life (Neuro-QOL) measurement systemJohn M Salsman, David Victorson, Seung W Choi, et al.
Psychological Test and Assessment Modeling|May 20, 2017
Measurement Equivalence of the Patient Reported Outcomes Measurement Information System<sup>®</sup> (PROMIS<sup>®</sup>) Applied Cognition - General Concerns, Short Forms in Ethnically Diverse GroupsRobert Fieo, Katja Ocepek-Welikson, Marjorie Kleinman, et al.
Breast Cancer Research and Treatment|January 21, 2009
Lapatinib plus capecitabine versus capecitabine alone for HER2+ (ErbB2+) metastatic breast cancer: quality-of-life assessmentXiaolei Zhou, David Cella, David Cameron, et al.
Anxiety, Stress, and Coping|January 13, 2015
Assessment of stress and self-efficacy for the NIH Toolbox for Neurological and Behavioral FunctionMary Jo Kupst, Zeeshan Butt, Catherine M Stoney, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|April 12, 2021
Past and Current Practice of Patient-Reported Outcome Measurement in Randomized Cancer Clinical Trials: A Systematic ReviewJohannes M Giesinger, Fabio Efficace, Neil Aaronson, et al.
Journal of Biopharmaceutical Statistics|February 15, 2024
[Special issue PRO] Considering endpoints for comparative tolerability of cancer treatments using patient report given the estimand frameworkJohn Devin Peipert, Monique Breslin, Ethan Basch, et al.
The Oncologist|September 9, 2008
Health-related quality of life impact of bevacizumab when combined with irinotecan, 5-fluorouracil, and leucovorin or 5-fluorouracil and leucovorin for metastatic colorectal cancerFairooz F Kabbinavar, Joel F Wallace, Eric Holmgren, et al.
Medical Care|May 18, 2010
Literacy-fair measurement of health-related quality of life will facilitate comparative effectiveness research in Spanish-speaking cancer outpatientsElizabeth A Hahn, Hongyan Du, Sofia F Garcia, et al.
Pageof 102